Clinical Trial Update: Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

View source ↗

Summary

This clinical trial entry notes ongoing recruitment to evaluate cardiovascular outcomes and risk in recipients of hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Peking University People's Hospital | Conditions: Hematopoietic Stem Cell Transplantation, Transplant Complication | Status: RECRUITING